EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism

Jose A Rodriguez iD, Adi Minis, Rasha Aref iD, Hieu Hoang Minh Nguyen iD, Fiona Sun iD, Hermann Steller iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2511899122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jose A Rodriguez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Strang Laboratory of Apoptosis and Cancer Biology, The Rockefeller University, New York, NY 10065. Hauptthemen laut MEDLINE: F-Box Proteins, Parkinsonian Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Pershing Square Foundation (PSF), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases present one of the most significant global health challenges. These disorders are defined by the accumulation of abnormal protein aggregates that impair synaptic function and cause progressive neuronal degeneration. Therefore, stimulating protein clearance mechanisms may be neuro-protective. Variants in FBXO7/PARK15 cause Parkinsonian Pyramidal Syndrome, an early-onset parkinsonian neurodegenerative disorder in humans, and inactivation of this gene in mice recapitulates many phenotypes seen in patients. The proteasome regulator PI31 is a direct binding partner of Fbxo7 and promotes local protein degradation at synapses by mediating fast proteasome transport in neurites. PI31 protein levels are reduced when the function of Fbxo7 is impaired. Here we show that restoring PI31 levels in Fbxo7 mutant fly and mouse strains prevents neuronal degeneration and significantly improves neuronal function, health, and lifespan. Notably, Fbxo7 inactivation in mouse neurons causes hyperphosphorylation of tau, and this was suppressed by transgenic expression of PI31. Our results demonstrate that PI31 is a crucial biological target through which Fbxo7 deficiency drives pathology. Therefore, targeting the PI31-pathway may represent a promising therapeutic approach for treating neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

F-Box ProteinsParkinsonian DisordersAnimalsMiceDisease Models, AnimalHumansNeuronsMice, Transgenictau ProteinsPhosphorylationProteasome Endopeptidase ComplexDrosophila melanogaster

Stichwörter der Autor:innen

axonal transportneurodegenerative diseaseproteostasissynapseubiquitin proteasome system

Substanzen

F-Box Proteinstau ProteinsProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Strang Laboratory of Apoptosis and Cancer Biology, The Rockefeller University, New York, NY 10065.

ORCID-Profile: Jose A Rodriguez, Rasha Aref, Hieu Hoang Minh Nguyen, Fiona Sun, Hermann Steller

Förderung

  • NIGMS NIH HHS
  • Pershing Square Foundation (PSF)
  • NIH HHS
  • NIH

Zitieren

APA

Rodriguez, J. A., Minis, A., Aref, R., Nguyen, H. H. M., Sun, F., & Steller, H. (2025). PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2511899122

Vancouver

Rodriguez JA, Minis A, Aref R, Nguyen HHM, Sun F, Steller H. PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2511899122

BibTeX
@article{Rodriguez2025,
  author = {Rodriguez, Jose A and Minis, Adi and Aref, Rasha and Nguyen, Hieu Hoang Minh and Sun, Fiona and Steller, Hermann},
  title = {PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2511899122}
}
Kostenlos starten →